BioDelivery Sciences Added to NASDAQ Biotechnology Index
December 19, 2019 08:30 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 27, 2019 08:30 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Nov. 27, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors
November 25, 2019 08:30 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Nov. 25, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations
November 12, 2019 16:01 ET
|
BioDelivery Sciences International
BELBUCA® Net Sales Increased by 115% versus Prior Year to All-time High of $26.5 Million Raises Full Year 2019 Total Company Net Sales Expectations to $105 - $110 Million Provides Full Year 2020...
BioDelivery Sciences to Present at the 10th Annual Jefferies Global Healthcare Conference in London
November 07, 2019 08:00 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients...
BioDelivery Sciences to Report Third Quarter 2019 Financial Results and Host Conference Call on November 12, 2019
October 30, 2019 08:00 ET
|
BioDelivery Sciences International
RALEIGH, N.C., Oct. 30, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions,...